A. Brunegraf

Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer

U. Haberkorn, G. Böning, C. Stief, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis

S. Ziegler, N. Albert, G. Böning, 2017, EJNMMI Research.

Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

S. Ziegler, G. Böning, P. Bartenstein, 2018, EJNMMI Research.

TSPO-PET for glioma imaging using the novel ligand [F-18]GE-180-first in human results in high-grade glioma patients

N. Albert, C. Belka, P. Bartenstein, 2017 .

TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

N. Albert, J. Tonn, C. Belka, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma

N. Albert, J. Tonn, C. Belka, 2017, European Journal of Nuclear Medicine and Molecular Imaging.